The availability of the α7 nicotinic acetylcholine receptor in recent-onset psychosis: a study using <sup>18</sup>F-ASEM PET.
Where this comes from
- Record sourced from PubMed, PMID 30573639.
- Also identified by DOI 10.2967/jnumed.118.213686.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Limited postmortem evidence suggests a diminished availability of the α7 nicotinic acetylcholine receptor (α7-nAChR) in hippocampus in psychosis. <b>Methods:</b> In this cross-sectional PET study, we used <sup>18</sup>F-ASEM, a radiotracer targeting the α7-nAChR, with positron emission tomography to compare the binding of <sup>18</sup>F-ASEM in hippocampus between individuals with recent-onset psychosis and healthy controls. <b>Results:</b> Individuals with recent-onset psychosis [non-affective psychosis (NP) or affective psychosis], and particularly those with NP, showed lower hippocampal binding of <sup>18</sup>F-ASEM than healthy controls. Among patients, lower binding was associated with lower performance in two cognitive domains after controlling for age. <b>Conclusion:</b> Low availability of the α7-nAChR in hippocampus may be linked to recent-onset of psychosis. Further study is needed to assess its clinical relationship to neuropsychiatric symptoms.